Immune Responses to Nanomaterials for Biomedical Applications
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (15 October 2020) | Viewed by 65056
Special Issue Editor
Interests: innate immune system; chemokines; nanomaterials; nanobiointeractions; adjuvants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has consolidated its success in the past years by producing novel devices and materials, which are currently applied in several fields of research and industry. Our interest is focused on biomedical applications of nanotechnologies to improve the therapeutics’ performances, as well as diagnostics. Successful nanodevices for drug or gene delivery, imaging or synthesized with materials acting per se (e.g., nanozimes) require full biocompatibility. Recent literature has highlighted the importance of host immune responses to nanomaterials as a critical issue to be addressed in order to create safe-by-design nanotools.
The present Special Issue would like to overcome the “classical nanotoxicology” as limited to toxicity results on cell death mechanisms, rather providing information on the several interactions that the immune system has with nanomaterials developed to biomedical applications. Novel results on immune cell, tissue or different animal models’ inflammatory responses to nanomaterials will be welcome, as well as critical review articles challenging the present knowledge and offering an expert platform to discussion.
Dr. Giuseppe Bardi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- biomedical applications
- immune-compatibility
- innate immune system
- adaptive immune system
- immune responses
- inflammation
- immune cells
- immune response
- inflammatory mediators
- cytokines
- chemokines
- phagocytosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.